首页> 中文期刊> 《南昌大学学报(医学版)》 >熊果酸对大鼠体内瑞舒伐他汀的药代动力学影响

熊果酸对大鼠体内瑞舒伐他汀的药代动力学影响

             

摘要

目的:探讨熊果酸对大鼠体内瑞舒伐他汀的药代动力学影响。方法12只雄性 SD 大鼠(200~235 g)按随机数字表法分为2组,分别为单用瑞舒伐他汀组与瑞舒伐他汀合用熊果酸组,每组6只,以瑞舒伐他汀100 mg· kg-1、熊果酸80 mg·kg-1的剂量灌胃给药,两药合用时先熊果酸后瑞舒伐他汀相继灌胃。采用 LC-MS 测定血药浓度,比较2组间药代动力学参数。结果合用熊果酸后,瑞舒伐他汀药代动力学参数 Cmax、AUC0-t、AUC0-∞参数值分别增加163.02%、145.99%和157.55%,而 CLz/F 值降低了57.84%(P <0.05或 P <0.01)。结论熊果酸可影响大鼠体内瑞舒伐他汀的药代动力学特性。%Objective To study the effect of ursolic acid on the pharmacokinetics of rosuvasta-tin in rats.Methods Twelve male rats(200-235 g)were randomly given rosuvastatin alone(con-trol group)or in combination with ursolic acid(treatment group),with 6 rats in each group.Rosu-vastatin(100 mg·kg-1 ),ursolic acid(80 mg·kg-1 )were adiministered by intragastric adminis-tration.Combination of both recipes were adiministered first ursolic acid.LC-MS was used to de-termine the plasma concentrations of rosuvastatin.Pharmacokinetic parameters were compared between the two groups.Results Compared with control group,Cmax ,AUC0-t and AUC0-∞ parame-ters were respectively increased by 163.02%,145.99% and 157.55%,but CLz/F was decreased by 57.84% in treatment group(P <0.05 or P <0.01).Conclusion Ursolic acid can affect the pharmacokinetic properties of rosuvastatin in rats.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号